Flores, Fernanda Faião; Suárez, José Agustin Quincoces; Fruet, Andrea Costa; Maria-Engler, Silvya Stuchi 
; Pardi, Paulo Celso; Maria, Durvanei Augusto
Source: PLOS ONE. Unidade: FCF
Subjects: FARMACOTERAPIA, AÇAFRÃO (COMPONENTES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FLORES, Fernanda Faião et al. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression. PLOS ONE, v. 10, n. 3, p. 1-16 art e0118702, 2015Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0118702. Acesso em: 10 abr. 2026.APA
Flores, F. F., Suárez, J. A. Q., Fruet, A. C., Maria-Engler, S. S., Pardi, P. C., & Maria, D. A. (2015). Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression. PLOS ONE, 10( 3), 1-16 art e0118702. doi:10.1371/journal.pone.0118702NLM
Flores FF, Suárez JAQ, Fruet AC, Maria-Engler SS, Pardi PC, Maria DA. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression [Internet]. PLOS ONE. 2015 ; 10( 3): 1-16 art e0118702.[citado 2026 abr. 10 ] Available from: https://doi.org/10.1371/journal.pone.0118702Vancouver
Flores FF, Suárez JAQ, Fruet AC, Maria-Engler SS, Pardi PC, Maria DA. Curcumin analog DM-1 in monotherapy or combinatory treatment with dacarbazine as a strategy to inhibit in vivo melanoma progression [Internet]. PLOS ONE. 2015 ; 10( 3): 1-16 art e0118702.[citado 2026 abr. 10 ] Available from: https://doi.org/10.1371/journal.pone.0118702
